Carbenicillin indanyl sodium, ampicillin, or cephalexin was administered orally to 61 patients with urinary tract infections. Assignment of drug was made by a computer-generated, randomized plan in a double-blind fashion. The rates of cure 4 weeks after therapy were 50, 42, and 50% for patients treated with carbenicillin, ampicillin, and cephalexin, respectively. Failure of therapy was correlated with chronicity of infection and sensitivity of the microorganism to the antibiotic used. Thirty-nine percent of the patients developed side effects, but there were no significant differences in side effects among the three antibiotics. This double-blind study demonstrates that carbenicillin indanyl sodium is as effective as ampicillin and cephalexin in treatment of urinary tract infections.
Carbenicillin indanyl sodium is an indanyl ester of carbenicillin which is absorbed after oral administration, and once absorbed it is rapidly hydrolyzed to carbenicillin (2) . Recently several studies have demonstrated that the indanyl ester of carbenicillin is effective in the treatment of urinary tract infections (1, 3, 4) . A previous single-blind study by the authors showed that carbenicillin indanyl sodium was as effective as ampicillin and cephaloglycin in treatment of urinary tract infections (3) .
The purpose of this study was to compare the indanyl ester of carbenicillin with oral ampicillin and cephalexin in treatment of patients with urinary tract infections by using a randomized plan of patient assignment in a double-blind fashion.
MATERIALS AND METHODS
Patients. Sixty-one patients (11 men and 50 women) with urinary tract infections were studied at the Hospital of the Medical College of Pennsylvania, the University of Virginia Hospital, and the University of Alabama Hospital and Clinics from December 1972 to February 1973. Criteria for inclusion in the study were as follows: (i) in asymptomatic patients, two or more quantitative urine cultures on different days demonstrating at least 106 of the same bacteria per ml of urine or in symptomatic patients, one culture with at least 10' bacteria per ml; (ii) no other antimicrobial therapy or instrumentation of the urinary tract during the period of study and follow-up; and (iii) no known allergies to the penicillins or cephalosporins, or both.
The following determinations were made before and after therapy: urinalysis, complete blood count, blood urea nitrogen, and serum creatinine, alkaline phosphatase, bilirubin, and glutamic oxaloacetic transaminase. Quantitative urine cultures were obtained during day 2, 3, 4, 5, or 6 of therapy, at the end of therapy, and 2 The results of therapy were classified as: (i) cure, when urine cultures were negative (< 104 bacteria per ml) during therapy and at follow-up; (ii) cure with reinfection, when urine cultures were negative during therapy but when reinfection (> 10' of a new organism per ml of urine) was noted 2 to 4 weeks after stopping therapy; (iii) persistence, when 10' or more of the initial infecting organism were found in the urine during therapy; (iv) superinfection, when reinfection developed during therapy; and (v) relapse, when 10' or more of the original infecting organisms per ml of urine were present at follow-up, after demonstration of less than 104 per ml on all cultures taken during therapy. Escherichia coli strains were serotyped to help differentiate between relapse and reinfection.
In vitro antibiotic susceptibility sensitivity tests. Susceptibilities of infecting microorganisms to disodium carbenicillin, ampicillin trihydrate, and cephalexin monohydrate were determined by an antibiotic dilution method in heart infusion broth at pH 7.4. The antibiotics were diluted in twofold steps in tubes containing 0.5 ml of broth. The inoculum for each tube was 0.5 ml of a 10-4 dilution of an 18-h culture of each strain in heart infusion broth at pH 7.4. The tubes were incubated at 37 C for 24 h and examined for turbidity. The minimal inhibitory end point was considered to be the minimal concentration of antibiotic that prevented turbidity.
RESULTS
Patients. Sixty-one patients were studied; 20 received carbenicillin indanyl sodium, 19 received ampicillin, and 22 received cephalexin.
ANTIMICROB. AG. CHEMOTHER. Infecting microorganisms. Table 2 lists the infecting microorganisms for each of the groups. There were no significant differences (P > 0.05) among the three groups as to proportion of E. coli or any other organisms. Figure 1 shows the minimal inhibitory concentrations of carbenicillin, ampicillin, and cephalexin for 58 of the infecting microorganisms. All three antibiotics were active against most of the organisms; 76 to 88% were inhibited by 31 ,ug of each drug per ml, concentrations easily achieved in the urine.
Results of therapy. The results of therapy are listed in Table 3 . Twenty-nine of the 61 patients (48%) treated with carbenicillin, ampicillin, or cephalexin became abacteriuric during therapy and remained abacteriuric during the entire follow-up period. There were no significant differences among the three groups in cure rates (even with "cure with reinfection" included as cures). Superinfection occurred in two patients in the carbenicillin group and one patient in the ampicillin group.
Twenty-four (39%) of the patients developed side effects during therapy; 8 patients were receiving carbenicillin, 10 patients were receiving ampicillin, and 6 patients were receiving cephalexin. Nine (38%) of the 24 patients developed more than one side effect. All individual side effects are listed in Table 4 . No other toxic effects (e.g., hematopoietic, renal, hepatic) other than those listed in Table 4 were observed. Nausea and vomiting of a severe enough degree Factors related to failure of therapy. Figure  2 illustrates the minimal inhibitory concentrations of carbenicillin for the strains isolated from patients treated with carbenicillin, ampicillin, and cephalexin. Strains from patients who were cured and strains from patients who were not cured are plotted separately. There was a high correlation between success of therapy and susceptibility of the infecting organism to carbenicillin, with less striking correlations for ampicillin or cephalexin. Ninety percent of the strains from patients cured with carbenicillin were inhibited by 62.5 jg of carbenicillin per ml, whereas only 55% of strains from patients that were not cured were inhibited by 62.5 Ag/ml. Patients with infections caused by organisms resistant to 500 ,g or more of carbenicillin, 7.8 jg of ampicillin, or 62.5 Ag of cephalexin per ml were not cured.
In all five patients in whom infection persisted, the infecting microorganism was highly resistant to the antibiotic given. Thirteen of the patients who relapsed were infected with organisms that were susceptible to the treatment antibiotic; none of the relapse stains changed in susceptibility to the antibiotic that was administered.
There was a correlation of chronicity of infec- tion with failure of therapy. Twenty-two of 40 patients (55%) with acute infections were cured; whereas 7 of 21 patients (33%) with chronic infections were cured. However these differences were not significant (P > 0.05).
DISCUSSION
The present double-blind study demonstrated that, in the patient population studied, there were no significant differences between carbenicillin indanyl sodium, ampicillin, and cephalexin in cure rates of urinary tract infection or in toxic side effects.
These results agree with a former single-blind study by the same authors in which no significant differences were found between carbenicillin indanyl sodium, ampicillin, and cephaloglycin in treatment of urinary tract infection (3) . In that study 1 g of carbenicillin indanyl ester was given four times a day, and the usual dose of ampicillin was 1 g four times a day; in the present study the doses of carbenicillin indanyl ester and ampicillin were 500 mg four times a day. Although the cure rates in the present study with lower doses of carbenicillin ANTIMICROB. AG. CHEMOTHER. and ampicillin were higher than in the previous study (50 and 42%, respectively, as compared with 33 and 32%), they were not statistically significantly different (P > 0.05 for both).
